Teladoc Health Inc
TDOCNASDAQStock · Data from SEC EDGAR 13F · Held by 7 of 87 tracked investors
Teladoc Health Inc at a glance
An overview of the financial statements, in plain language. Switch to the advanced view for charts.
- Valuation15
- Growth34
- Profitability12
- Quality33
- Debt86
- Stability34
- ✓It could repay its net debt from free cash flow in 1.4 years.
- ✓The analysts' average target is 16% above the price.
- !The company is loss-making: net profit is negative.
- !Revenue grew only 1.7% a year over 3 years.
The score describes the quality and the past of the company based on its statements (the FinBoss model, indicative). A high score is not a buy signal and a low one is not a sell signal. Data source: Yahoo Finance, prices and statements in USD.
Is the stock expensive?
ExpensiveThe company has no earnings, so the P/E cannot be calculated.
- P/E
- –
- P/S
- 0.5×
- EV/EBITDA
- 21.6×
Is the company growing?
FlatRevenue over 3 years grew 1.7% a year. Last year -4.0%.
Does it make money?
Loss-makingChart TDOC
Insider purchases
last 90 days, SEC Form 4Which investors hold this stock
7PF Pale Fire Capital Pale Fire Capital SE | 1.18% |
JS Jim Simons Renaissance Technologies | 0.09% |
SC Steven Cohen Point72 Asset Management | 0.08% |
CA Cliff Asness AQR Capital Management | 0.01% |
RD Ray Dalio Bridgewater Associates | 0% |
LB Louis Bacon Moore Capital Management | 0% |
KF Ken Fisher Fisher Investments | 0% |
Frequently asked questions
How much is Teladoc Health Inc (TDOC) stock?
Teladoc Health Inc shares trade at $6.45, +3.37% over the last trading day. The price is delayed.
What is the market cap of Teladoc Health Inc?
The market cap of Teladoc Health Inc is about $1.2B.
Which big investors hold Teladoc Health Inc?
According to the latest 13F filings, 7 of 87 tracked investors hold Teladoc Health Inc, for example Pale Fire Capital, Jim Simons, Steven Cohen.
When will Teladoc Health Inc report its next results?
The next earnings report of Teladoc Health Inc is expected on 28 Oct 2026.
Source: SEC EDGAR 13F-HR (quarterly filings). The data is indicative and is not investment advice.